Kymera Therapeutics, Inc.
KYMR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815442
In the last 90 days, Kymera Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 276 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Kymera Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- −22 vs. Q1 2022
- Shares held
- 49.4M
- +3.77M (+8.3%) vs. Q1 2022
- Total value
- $973.6M
- −$958.1M (−49.6%) vs. Q1 2022
- New holders
- 13
- 42 more added
- Sold out
- 35
- 30 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 276 | $11.1B |
| Q1 2026 | 256 | $8.01B |
| Q4 2025 | 255 | $6.99B |
| Q3 2025 | 210 | $4.58B |
| Q2 2025 | 210 | $3.44B |
| Q1 2025 | 174 | $2.00B |
| Q4 2024 | 181 | $2.89B |
| Q3 2024 | 176 | $3.27B |
| Q2 2024 | 157 | $2.01B |
| Q1 2024 | 164 | $2.70B |
| Q4 2023 | 137 | $1.54B |
| Q3 2023 | 122 | $797.2M |
| Q2 2023 | 129 | $1.34B |
| Q1 2023 | 127 | $1.68B |
| Q4 2022 | 121 | $1.40B |
| Q3 2022 | 128 | $1.15B |
| Q2 2022 | 101 | $973.6M |
| Q1 2022 | 126 | $1.93B |
| Q4 2021 | 128 | $2.76B |
| Q3 2021 | 115 | $2.04B |
| Q2 2021 | 110 | $1.29B |
| Q1 2021 | 97 | $887.2M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Kymera Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $135.4M | 22.63% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −652,800−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −368,061−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −227,034−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −199,244−100.0% | Sold out |
| Clough Capital Partners L P | 0 | $0 | 0.00% | −185,700−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −183,750−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −180,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −172,800−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −74,658−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −52,400−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Eagle Health Investments LP | 0 | $0 | 0.00% | −37,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −33,240−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −29,215−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,470−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −12,048−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,790−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −9,384−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −9,014−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −8,803−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −8,242−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −8,096−100.0% | Sold out |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −7,700−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −7,640−100.0% | Sold out |
| Integrated Advisors Network LLC | 0 | $0 | 0.00% | −6,218−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −6,085−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −5,755−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −5,588−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −4,780−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −2,477−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,263−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −136−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Teachers Retirement System of the State of Kentucky | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |